Accessibility settings

This paper is in the following e-collection/theme issue:

Reviews on Public Health Technology and Innovation (89) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (232) Infoveillance, Infodemiology, Digital Disease Surveillance, Infodemic Management (1176) Registered Report (881) Social Media in Public Health informatics (73)

Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/59167, first published .
Person using a smartphone with the Twitter app open outdoors

The Value of Social Media Analysis for Adverse Events Detection and Pharmacovigilance: Scoping Review

The Value of Social Media Analysis for Adverse Events Detection and Pharmacovigilance: Scoping Review

Authors of this article:

Su Golder1 Author Orcid Image ;   Karen O'Connor2 Author Orcid Image ;   Yunwen Wang3 Author Orcid Image ;   Ari Klein2 Author Orcid Image ;   Graciela Gonzalez Hernandez3 Author Orcid Image
Article Authors Cited by (14) Tweetations Metrics

Journals

  1. Silva P, Rogers S, Hassan-Toufique Z, Tao J, Bruce S, Shireman P, Ramos K. Idealized Framework for Assisting Pharmacovigilance Reporting in an Ambulatory Primary Care and Chronic Disease Management Clinic. Pharmacoepidemiology 2025;4(4):26 View
  2. Shahrezaei A, Taherkhani S, Dashti L, Garmaroodi G, Nasirinezhad F. Herbal medicine meets machine learning: a systematic review of AI-powered innovation in chronic inflammation management. Discover Applied Sciences 2025;8(2) View
  3. Phillips B. Towards evidence-based medicine for paediatricians. Archives of Disease in Childhood 2026;111(2):193.2 View
  4. Ried P, Seifert R. Social media data and its potential for pharmacovigilance: a comparative analysis of reported prevalences regarding drug-induced gingival overgrowth (DIGO). Naunyn-Schmiedeberg's Archives of Pharmacology 2026;399(7):9673 View
  5. Guellil I, Berrachedi Y, Chenni N, Abboud M, Wu J, Wu H, Alex B. Detecting Adverse Drug Events in Social Media: A Brief Literature Review. SN Computer Science 2026;7(2) View
  6. Nagem Lopes L, Ramos-Silva A, Gallo de Castro A, Corrêa de Matos G. Potential utility of social media in pharmacovigilance to identify adverse events and safety signals: a scoping review. Research in Social and Administrative Pharmacy 2026;22(5):617 View
  7. Sehgal N, Tronieri J, Ungar L, Guntuku S. Self-reported side effects of semaglutide and tirzepatide in online communities. Nature Health 2026 View
  8. Liu S, Liu J. Large Language Model–Based Analysis of Statin Therapy Discussions and Sentiment on Social Media: Cross-Sectional Observational Study. Journal of Medical Internet Research 2026;28:e85057 View
  9. Dong F, Guo W, Liu J, Varghese A, Tong W, Patterson T, Hong H. BERT-Based Models for Normalization of Adverse Drug Event Expressions in Social Media to Standard Medical Terminology for Drug Safety Analysis. Big Data and Cognitive Computing 2026;10(5):141 View
  10. Oh S, Park D, Song Y. Comparative Analysis of Potential Side Effects of Targeted Oral Hypoglycemic Agents Using Spontaneous Adverse Event Reports and Social Media Data. Pharmacoepidemiology and Drug Safety 2026;35(5) View
  11. Baldacchino A, Schofield J, Mitka G. Contextualizing innovation in addiction psychiatry: opportunities to deliver precision medicine in a complex clinical system. Current Opinion in Psychiatry 2026 View

Books/Policy Documents

  1. Chinzowu T, Nishtala P. Reference Module in Biomedical Sciences. View
  2. Chinzowu T, Nishtala P. Reference Module in Biomedical Sciences. View
  3. Chinzowu T, Nishtala P. Reference Module in Biomedical Sciences. View